Seres Therapeutics Stock Forecast - Simple Exponential Smoothing

MCRB Stock  USD 0.58  0.05  7.94%   
The Simple Exponential Smoothing forecasted value of Seres Therapeutics on the next trading day is expected to be 0.58 with a mean absolute deviation of  0.04  and the sum of the absolute errors of 2.15. Seres Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Seres Therapeutics stock prices and determine the direction of Seres Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Seres Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Seres Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Seres Therapeutics' systematic risk associated with finding meaningful patterns of Seres Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Seres Therapeutics to cross-verify your projections.
For information on how to trade Seres Stock refer to our How to Trade Seres Stock guide.
  
At present, Seres Therapeutics' Inventory Turnover is projected to increase slightly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 1.02, whereas Payables Turnover is forecasted to decline to 3.94. . The current year's Common Stock Shares Outstanding is expected to grow to about 134.4 M, whereas Net Loss is projected to grow to (213.9 M).

Open Interest Against 2024-04-19 Seres Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Seres Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Seres Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Seres Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Seres Therapeutics' open interest, investors have to compare it to Seres Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Seres Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Seres. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Seres Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Seres Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Seres Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Seres Therapeutics simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Seres Therapeutics are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Seres Therapeutics prices get older.

Seres Therapeutics Simple Exponential Smoothing Price Forecast For the 20th of April

Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Seres Therapeutics on the next trading day is expected to be 0.58 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.15.
Please note that although there have been many attempts to predict Seres Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Seres Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Seres Therapeutics Stock Forecast Pattern

Backtest Seres TherapeuticsSeres Therapeutics Price PredictionBuy or Sell Advice 

Seres Therapeutics Forecasted Value

In the context of forecasting Seres Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Seres Therapeutics' downside and upside margins for the forecasting period are 0.01 and 5.05, respectively. We have considered Seres Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.58
0.58
Expected Value
5.05
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Seres Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Seres Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria110.1123
BiasArithmetic mean of the errors 0.0095
MADMean absolute deviation0.0358
MAPEMean absolute percentage error0.0383
SAESum of the absolute errors2.15
This simple exponential smoothing model begins by setting Seres Therapeutics forecast for the second period equal to the observation of the first period. In other words, recent Seres Therapeutics observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Seres Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Seres Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Seres Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.484.95
Details
Intrinsic
Valuation
LowRealHigh
0.142.897.36
Details
7 Analysts
Consensus
LowTargetHigh
8.959.8310.91
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.43-0.34-0.26
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Seres Therapeutics. Your research has to be compared to or analyzed against Seres Therapeutics' peers to derive any actionable benefits. When done correctly, Seres Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Seres Therapeutics.

Other Forecasting Options for Seres Therapeutics

For every potential investor in Seres, whether a beginner or expert, Seres Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Seres Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Seres. Basic forecasting techniques help filter out the noise by identifying Seres Therapeutics' price trends.

Seres Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Seres Therapeutics stock to make a market-neutral strategy. Peer analysis of Seres Therapeutics could also be used in its relative valuation, which is a method of valuing Seres Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Seres Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Seres Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Seres Therapeutics' current price.

Seres Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Seres Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Seres Therapeutics shares will generate the highest return on investment. By undertsting and applying Seres Therapeutics stock market strength indicators, traders can identify Seres Therapeutics entry and exit signals to maximize returns.

Seres Therapeutics Risk Indicators

The analysis of Seres Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Seres Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting seres stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Seres Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Seres Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Seres Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Seres Therapeutics Stock:
Check out Historical Fundamental Analysis of Seres Therapeutics to cross-verify your projections.
For information on how to trade Seres Stock refer to our How to Trade Seres Stock guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Seres Stock analysis

When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Seres Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Seres Therapeutics. If investors know Seres will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Seres Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.89)
Revenue Per Share
0.987
Quarterly Revenue Growth
(0.93)
Return On Assets
(0.19)
Return On Equity
(5.39)
The market value of Seres Therapeutics is measured differently than its book value, which is the value of Seres that is recorded on the company's balance sheet. Investors also form their own opinion of Seres Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Seres Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Seres Therapeutics' market value can be influenced by many factors that don't directly affect Seres Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Seres Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Seres Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Seres Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.